Sandoz has signed an agreement with mAbxience to develop and commercialise an emicizumab biosimilar referencing Roche's Hemlibra, targeting haemophilia A.
iStock
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Royal Colleges have asked the MHRA to update propranolol’s Summary of Product Characteristics.
iStock
Sandoz has received marketing authorisation from Health Canada for Sandoz Semaglutide, a GLP-1 receptor agonist injection and generic version of Ozempic
iStock
The MHRA has urged healthcare providers, carers and anyone using a hoist to follow its guidance and ensure the safety of the equipment before use.
iStock
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.